Natural Gels for Treatment of Plaque Psoriasis
Safety and Efficacy of Natural Gel Combination and Hair Mask of Plant Origin in Patients With Psoriasis: A Randomized, Double-Blind, Placebo (Vehicle) Controlled
1 other identifier
interventional
45
1 country
1
Brief Summary
The aim of the study is to evaluate the safety and the therapeutic activity of the combination of Natural Gel combination and hair mask of plant origin in patients with mild to moderate plaque psoriasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2014
CompletedFirst Posted
Study publicly available on registry
January 1, 2015
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJuly 23, 2018
July 1, 2018
1.8 years
December 30, 2014
July 19, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Modified Psoriasis Assessment severity index
up to 16 weeks
Study Arms (2)
patients
ACTIVE COMPARATORnatural gels
subjects
PLACEBO COMPARATORThese patients will receive that placebo (vehicle) products.
Interventions
Eligibility Criteria
You may qualify if:
- Subjects with stable (for at least 6 months), mild to moderate (less than 10% of the skin surface area) plaque psoriasis.
- Male and female ≥ 18 years old.
- Subject is capable of giving a written informed consent.
You may not qualify if:
- Subjects treated by topical or photo or systemic anti psoriatic therapy during 4 weeks prior to the study.
- Subjects treated with Biological products for psoriasis for the last 3 months prior to starting the present study.
- Subjects with any other type of psoriasis but vulgaris (plaque ).
- Use of investigational agents \< 30 days prior to the study.
- Low compliance.
- Subjects who are mentally or physically unable to comply with all aspects of the study.
- Pregnant women.
- Known allergic reaction to fragrance or any ingredient of the test products.
- Other inflammatory skin disease in the treatment area that may confound the evaluation of the psoriasis.
- A medical condition that may put the patient at a general risk and therefore would prevent participation in the clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Secret of Youthlead
Study Sites (1)
Chaim Sheba Med. center. Dept. Of Dermatology
Reamat- Gan, Ramat-almogi, 34793, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felix Pavlotzky, MD
Chaim sheba Medical Center, Dept. of Dermatolgy. Tel-Hashomer, Israel
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2014
First Posted
January 1, 2015
Study Start
January 1, 2015
Primary Completion
November 1, 2016
Study Completion
September 1, 2017
Last Updated
July 23, 2018
Record last verified: 2018-07